Great Valley Advisor Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.29M Buy
12,193
+1,049
+9% +$374K 0.08% 224
2025
Q4
$3.65M Buy
11,144
+190
+2% +$60.3K 0.07% 239
2025
Q3
$3.09M Buy
10,954
+1,303
+14% +$378K 0.06% 252
2025
Q2
$2.7M Sell
9,651
-494
-5% -$140K 0.06% 261
2025
Q1
$3.16M Sell
10,145
-9,206
-48% -$2.72M 0.07% 242
2024
Q4
$5.04M Buy
19,351
+1,443
+8% +$428K 0.11% 170
2024
Q3
$5.77M Buy
17,908
+10,136
+130% +$3.32M 0.14% 155
2024
Q2
$2.43M Buy
7,772
+686
+10% +$202K 0.07% 261
2024
Q1
$2.01M Buy
7,086
+71
+1% +$20.8K 0.06% 275
2023
Q4
$2.02M Buy
7,015
+155
+2% +$42.2K 0.07% 238
2023
Q3
$1.84M Sell
6,860
-284
-4% -$70.9K 0.08% 228
2023
Q2
$1.59M Sell
7,144
-554
-7% -$129K 0.07% 249
2023
Q1
$1.86M Buy
7,698
+1,020
+15% +$250K 0.09% 219
2022
Q4
$1.75M Sell
6,678
-150
-2% -$40.2K 0.09% 233
2022
Q3
$1.54M Sell
6,828
-112
-2% -$27.1K 0.09% 228
2022
Q2
$1.69M Buy
6,940
+580
+9% +$142K 0.09% 216
2022
Q1
$1.52M Sell
6,360
-17
-0.3% -$3.91K 0.09% 228
2021
Q4
$1.43M Sell
6,377
-371
-5% -$78.3K 0.09% 224
2021
Q3
$1.44M Buy
6,748
+76
+1% +$17.5K 0.1% 207
2021
Q2
$1.63M Buy
6,672
+31
+0.5% +$7.63K 0.12% 186
2021
Q1
$1.65M Sell
6,641
-116
-2% -$27.7K 0.16% 145
2020
Q4
$1.55M Buy
6,757
+359
+6% +$82.8K 0.16% 141
2020
Q3
$1.63M Buy
6,398
+115
+2% +$28.5K 0.2% 109
2020
Q2
$1.48M Buy
6,283
+596
+10% +$136K 0.24% 114
2020
Q1
$1.15M Sell
5,687
-43
-0.8% -$9.39K 0.31% 102
2019
Q4
$1.38M Buy
5,730
+52
+0.9% +$11.5K 0.31% 97
2019
Q3
$1.1M Buy
5,678
+3
+0.1% +$576 0.27% 113
2019
Q2
$1.05M Sell
5,675
-266
-4% -$47.6K 0.26% 122
2019
Q1
$1.13M Buy
5,941
+97
+2% +$18.5K 0.36% 79
2018
Q4
$1.14M Buy
+5,844
New +$1.14M 0.43% 61

Other funds holding AMGN

Great Valley Advisor Group's AMGN Position: Q1 2026 in Review

Great Valley Advisor Group increased its Amgen (AMGN) stake by 9.4% in Q1 2026, buying an estimated $374K and bringing the position to 12,193 shares worth $4.29M. The position accounts for 0.08% of the portfolio, ranked #224.

Great Valley Advisor Group first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.77M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Great Valley Advisor Group held 12,193 shares of Amgen worth $4.29M as of Q1 2026.
  • Great Valley Advisor Group bought 1,049 Amgen shares in Q1 2026, an estimated $374K.
  • Amgen made up 0.08% of Great Valley Advisor Group's portfolio in Q1 2026, its #224 holding.
  • Great Valley Advisor Group first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Great Valley Advisor Group's Amgen position peaked at $5.77M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.